Which medication is indicated for opioid use disorder during pregnancy despite risks?

Buprenorphine is indicated for the treatment of opioid use disorder (OUD) during pregnancy, even though there are potential risks involved. This medication belongs to a class of drugs known as partial opioid agonists. It effectively reduces cravings and withdrawal symptoms without producing the same intense euphoric effects as full agonists like oxycodone. This decreased euphoric effect lowers the risk of misuse while still providing adequate care for individuals with OUD.

In the context of pregnancy, buprenorphine has been shown to help stabilize the mother and reduce the risk of neonatal abstinence syndrome (NAS) when used appropriately under medical supervision. It is important to provide support and treatment tailored to the needs of pregnant individuals, as the benefits of stabilizing opioid use typically outweigh the potential risks associated with the medication.

While other options may relate to opioid management or treatments, they do not hold the same indication or safety profile for use during pregnancy. For example, naloxone is primarily an emergency treatment for opioid overdose and does not treat OUD itself. Oxycodone is a full opioid agonist that carries a high risk of misuse and complications during pregnancy. Carfentanil is an extremely potent opioid typically used as a tranquilizer for large animals and